Michelle Petri, MD MPH
No bio available.
Financial relationships
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Emergent BiosciencesTopic:SLEDate added:01/21/2024Date updated:01/21/2024
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Exo TherapeuticsTopic:SLEDate added:01/21/2024Date updated:01/21/2024Relationship end date:12/31/2023
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:GentibioTopic:SLEDate added:01/21/2024Date updated:01/21/2024
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:GSKTopic:SLEDate added:01/21/2024Date updated:01/21/2024
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Horizon TherapeuticsTopic:SLEDate added:01/21/2024Date updated:01/21/2024
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:iCell Gene TherapeuticsTopic:SLEDate added:01/21/2024Date updated:01/21/2024
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:IQVIATopic:SLEDate added:01/21/2024Date updated:01/21/2024Relationship end date:12/31/2023
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Idorsia PharmaceuticalsTopic:SLEDate added:01/21/2024Date updated:01/21/2024Relationship end date:07/31/2022
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Kira PharmaceuticalsTopic:SLEDate added:01/21/2024Date updated:01/21/2024Relationship end date:03/31/2023
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Eli LillyTopic:SLEDate added:01/21/2024Date updated:01/21/2024Relationship end date:12/31/2022